Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48.8M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
3.12M
-
Shares change
-
+1.08M
-
Total reported value, excl. options
-
$646K
-
Value change
-
+$222K
-
Number of buys
-
15
-
Number of sells
-
-7
-
Price
-
$0.21
Significant Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q3 2025
28 filings reported holding ASBP - Aspire Biopharma Holdings, Inc. - Common Stock as of Q3 2025.
Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.12M shares
of 48.8M outstanding shares and own 6.39% of the company stock.
Largest 10 shareholders include Crewe Advisors LLC (813K shares), Procyon Advisors, LLC (473K shares), VANGUARD GROUP INC (429K shares), Optivise Advisory Services LLC (264K shares), GEODE CAPITAL MANAGEMENT, LLC (250K shares), Antara Capital LP (203K shares), VR Advisory Services Ltd (97.4K shares), Resolute Advisors LLC (82.8K shares), Three Seasons Wealth, LLC (75K shares), and P SCHOENFELD ASSET MANAGEMENT LP (58.6K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.